Photon-counting detector CT with iodine quantification: improved distinction between bland and neoplastic portal vein thrombosis - Summary - MDSpire

Photon-counting detector CT with iodine quantification: improved distinction between bland and neoplastic portal vein thrombosis

  • By

  • Müller, Lukas

  • Jorg, Tobias

  • Grunz, Jan-Peter

  • Graafen, Dirk

  • Mähringer-Kunz, Aline

  • Moos, Maximilian

  • Foerster, Friedrich

  • Huflage, Henner

  • Pinto dos Santos, Daniel

  • Ligorio, Matteo

  • Scholz, Constantin

  • Bäuerle, Tobias

  • Emrich, Tilman

  • Kloeckner, Roman

  • March 6, 2026

  • 0 min

Share

Objective:

To evaluate the role of iodine density (ID) measurements in differentiating between bland and neoplastic portal vein thrombosis (PVT) in patients with hepatocellular carcinoma (HCC) and other malignancies using photon-counting detector CT (PCD-CT).

Key Findings:
  • ID measurements using PCD-CT effectively differentiate between bland and neoplastic PVT.
  • The portal venous phase is identified as a suitable phase for ID assessment.
  • PCD-CT provides spectral information without the need for preselection, reducing radiation exposure.
Interpretation:

The study demonstrates that PCD-CT-derived ID can enhance the differentiation of PVT types, which is crucial for treatment planning in HCC and other malignancies.

Limitations:
  • The study is retrospective and relies on consensus rather than histopathological confirmation for PVT classification.
  • Limited availability of PCD-CT scanners may affect the generalizability of the findings.
Conclusion:

PCD-CT with ID quantification is a promising tool for distinguishing between bland and neoplastic PVT, potentially improving clinical outcomes in patients with liver malignancies.

Original Source(s)

Related Content